UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Dabrafenib in BRAF -mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

The Lancet (British edition), 2012-07, Vol.380 (9839), p.358-365

2012

Volltextzugriff (PDF)

Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)

Journal of cancer research and clinical oncology, 2022-04, Vol.148 (4), p.955-965

2022

Volltextzugriff (PDF)

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression

Cancer Immunology, Immunotherapy, 2007-07, Vol.56 (7), p.1017-1024

2007

Volltextzugriff (PDF)

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

PloS one, 2015-03, Vol.10 (3), p.e0118564

2015

Volltextzugriff (PDF)

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors

Cancer Immunology, Immunotherapy, 2014-04, Vol.63 (4), p.381-394

2014

Volltextzugriff (PDF)

Anti-cytotoxic T-cell lymphocyte antigen-4-induced regression of spinal cord metastases in association with renal failure, atypical pneumonia, vision loss, and hearing loss

Journal of clinical oncology, 2012-11, Vol.30 (33), p.e356-e357

2012

Volltextzugriff (PDF)

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

Journal of translational medicine, 2015-11, Vol.13 (351), p.351-351, Article 351

2015

Volltextzugriff (PDF)

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

Cancer Immunology, Immunotherapy, 2012-11, Vol.61 (11), p.2091-2103

2012

Volltextzugriff (PDF)

STREAM: A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (S) treatment of chemonaïve patients (pts) with metastatic uveal melanoma (MUM)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9511-9511

2017

Volltextzugriff (PDF)

A new way to generate cytolytic tumor-specific T cells : electroporation of RNA coding for a T cell receptor into T lymphocytes

Cancer Immunology, Immunotherapy, 2006-09, Vol.55 (9), p.1132-1141

2006

Volltextzugriff (PDF)

Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation

The Journal of immunology (1950), 2005-03, Vol.174 (5), p.3087-3097

2005

Volltextzugriff (PDF)

Autocrine TNF is critical for the survival of human dendritic cells by regulating BAK, BCL-2, and FLIPL

The Journal of immunology (1950), 2012-05, Vol.188 (10), p.4810-4818

2012

Volltextzugriff (PDF)

Predictable clinical responses to sorafenib in stage IV uveal melanoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e19032-e19032

2012

Volltextzugriff (PDF)

Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers

Cancer immunology research, 2016-01, Vol.4 (1), p.18-25

2016

Volltextzugriff (PDF)

Efficient elutriation of monocytes within a closed system (Elutra™) for clinical-scale generation of dendritic cells

Journal of immunological methods, 2005-03, Vol.298 (1), p.61-72

2005

Volltextzugriff (PDF)

Human dendritic cells efficiently phagocytose adenoviral oncolysate but require additional stimulation to mature

International journal of cancer, 2012-04, Vol.130 (7), p.1682-1694

2012

Volltextzugriff (PDF)

Cell tracking using multimodal imaging

Contrast media and molecular imaging, 2013-11, Vol.8 (6), p.432-438

2013

Volltextzugriff (PDF)

Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection

Journal of immunotherapy, 2007-09, Vol.30 (6), p.663-674

2007

Volltextzugriff (PDF)

Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma

Journal of immunotherapy, 2009-06, Vol.32 (5), p.524-538

2009

Volltextzugriff (PDF)

A fast and robust method to clone and functionally validate T-cell receptors

Journal of immunological methods, 2009-07, Vol.346 (1), p.45-54

2009

Volltextzugriff (PDF)

Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells

European Journal of Immunology, 2007-04, Vol.37 (4), p.954-965

2007

Volltextzugriff (PDF)

Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report

Journal of neurosurgery, 2004-05, Vol.100 (5 Suppl Pediatrics), p.492

2004

Volltextzugriff (PDF)

An update on BREAK-3, a phase III, randomized trial: Dabrafenib (DAB) versus dacarbazine (DTIC) in patients with BRAF V600E-positive mutation metastatic melanoma (MM)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.9013-9013

2013

Volltextzugriff (PDF)

Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes

Cancer Immunology, Immunotherapy, 2008-04, Vol.57 (4), p.467-477

2008

Volltextzugriff (PDF)

Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.8532-8532

2012

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(61)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(45)
Humans
(39)
Immunology
(32)
Biological And Medical Sciences
(24)
Dendritic Cells - Immunology
(20)
Animals
(19)
Mice
(16)
Female
(15)
Cells, Cultured
(14)
Fundamental And Applied Biological Sciences. Psychology
(14)
Immunotherapy
(13)
Oncology
(13)
Dendritic Cells - Cytology
(12)
Medicine, Research & Experimental
(12)
Mice, Inbred Balb C
(12)
Research & Experimental Medicine
(12)
Dendritic Cells - Metabolism
(11)
Male
(11)
Melanoma
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dabrafenib in BRAF -mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors

Anti-cytotoxic T-cell lymphocyte antigen-4-induced regression of spinal cord metastases in association with renal failure, atypical pneumonia, vision loss, and hearing loss

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

STREAM: A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (S) treatment of chemonaïve patients (pts) with metastatic uveal melanoma (MUM)

A new way to generate cytolytic tumor-specific T cells : electroporation of RNA coding for a T cell receptor into T lymphocytes

Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation

Autocrine TNF is critical for the survival of human dendritic cells by regulating BAK, BCL-2, and FLIPL

Predictable clinical responses to sorafenib in stage IV uveal melanoma

Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers

Efficient elutriation of monocytes within a closed system (Elutra™) for clinical-scale generation of dendritic cells

Human dendritic cells efficiently phagocytose adenoviral oncolysate but require additional stimulation to mature

Cell tracking using multimodal imaging

Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection

Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma

A fast and robust method to clone and functionally validate T-cell receptors

Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells

Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report

An update on BREAK-3, a phase III, randomized trial: Dabrafenib (DAB) versus dacarbazine (DTIC) in patients with BRAF V600E-positive mutation metastatic melanoma (MM)

Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes

Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study

Suchergebnisse filtern